title: Antioxidants attenuate multiple phases of formalin-induced nociceptive response in mice.
abstract: An emerging theme in the study of the pathophysiology of chronic and persistent pain is the role of pro-oxidant substances. Reactive oxygen species (ROS) have been implicated in contributing to and/or maintaining conditions of chronic pain. Recent pre-clinical reports suggest that antioxidants are effective analgesics in neuropathic and inflammatory pain models. The present study extends this work by examining the effect of three antioxidants on tissue injury-induced nociception. C57BL6 mice (20-25 g) were pretreated with either phenyl-N-tert-butylnitrone (PBN; 50 mg/kg, i.p.), 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxy (TEMPOL; 200 or 50 mg/kg, i.p.), N-acetyl-L-cysteine (NAC; 200 or 100mg/kg, i.p.), or vehicle (0.5 ml/100 g), 5 min before intraplantar formalin (10%, 20 microl) injection. Nociceptive responding, indicated by licking or biting the affected hindlimb, was quantified for 30 min after formalin injection. Each drug was effective in attenuating two or more phases (acute, quiescent, and tonic) of the formalin response. To assess putative site of action, intrathecal TEMPOL (380 nmol/5 microl, i.t.) was given 5 min before intraplantar formalin. Intrathecal TEMPOL produced a 83% reduction in nociceptive responding in the tonic phase, but no significant attenuation of the acute phase response. To confirm that the antioxidant property of intrathecal TEMPOL was responsible for its analgesic effect on the formalin-induced pain response, intrathecal TEMPOL was coadministered with the free radical donor tert-butylhydroperoxide (tert-BuOOH). Tert-BuOOH coadminstration reversed the TEMPOL-induced analgesia in the tonic intraplantar formalin response reduction. The data suggest that pro-oxidant species may be important mediators of tissue injury-induced algesia in rodents, and that a spinal site of action is implicated in the tonic response.
authors.affiliation: Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, 1645 Neil Avenue, Columbus, OH 43210, USA.
authors.forename: A
authors.initials: A
authors.lastname: Hacimuftuoglu
authors.forename: C R
authors.initials: CR
authors.lastname: Handy
authors.forename: V M
authors.initials: VM
authors.lastname: Goettl
authors.forename: C G
authors.initials: CG
authors.lastname: Lin
authors.forename: S
authors.initials: S
authors.lastname: Dane
authors.forename: R L
authors.initials: RL
authors.lastname: Stephens
mesh_terms: D000111:Acetylcysteine / Q000627:therapeutic use; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001522:Behavior, Animal / Q000187:drug effects; D003497:Cyclic N-Oxides / Q000627:therapeutic use; D005260:Female; D005557:Formaldehyde; D007278:Injections, Spinal / Q000379:methods; D008297:Male; D051379:Mice; D009589:Nitrogen Oxides / Q000627:therapeutic use; D010146:Pain / Q000139:chemically induced / Q000517:prevention & control*; D010147:Pain Measurement / Q000379:methods; D013113:Spin Labels; D013997:Time Factors
chemical_list: D000975:Antioxidants; D003497:Cyclic N-Oxides; D009589:Nitrogen Oxides; D013113:Spin Labels; D005557:Formaldehyde; C029217:phenyl-N-tert-butylnitrone; C001803:tempol; D000111:Acetylcysteine